Morten Sondergaard
Alexander Spencer-Churchill
The Birley Group

Tom Speechley

New York, NY, USA

Co-Founder & CEO

SX2 Ventures

Tom Speechley


Tom Speechley is an early stage investor and business builder. He co-founded SX2 Ventures which builds and invests in innovative businesses in the human care sector focusing on life sciences, longevity, specialised care and emerging market healthtech.

Having initially worked as a corporate lawyer in London and New York, the majority of Tom’s 25-year career has been in global private equity and venture capital including several emerging markets.

Tom has sat on a number corporate and not-for profit boards including the Emerging Markets Private Equity Association and Junior Achievement Worldwide. He has been a senior advisor to and is a Fellow of the Royal Society of Arts in the United Kingdom.

Tom has written and spoken widely on emerging market private equity and venture capital and guest lectured at a number of leading universities in the United States. He has been a featured speaker on emerging market healthcare issues at the World Economic Forum in Davos, the United Nations and the Annual Meeting of the Inter-American Development Bank. He is the author of two books on acquisition finance and whilst a student at university coded a series of educational software programs that were among the first used in the UK’s national curriculum on computer studies.

At university Mr Speechley initially studied chemical physics before switching to law, graduating with First Class Honours from the University of Sheffield UK.

Tom Speechley’s Newsfeed

Ten Things We All Need to Know about Dementia

Tom Speechley, Co-Founder & CEO of SX2 Ventures, discusses the ten things about dementia all individuals should know. Dementia is the number one cause of death in the UK, there is no known cure and the NHS will not treat you for it. However, it is possible to materially reduce the risk of developing it.

Measuring Investment Success in the Age of Millennials

Tom Speechley writes: "Impact investing should not be confined to gifting benefits in tightly defined arenas such as free vaccinations in Africa. Trade-offs are not an inevitable outcome of impact investing. With careful investment selection, “trade-ons” are very much achievable."

View allHide

Tom Speechley’s Background

Co-Founder & CEO
New York, NY, USA
SX2’s focus is exclusively on projects that provide solutions in the evolving areas of life sciences including nutraceuticals, longevity, specialized care including eldercare, mental illness and end-of-life care and emerging market healthtech.

Other Business Interests

qbeats inc. logo qbeats inc. logo
qbeats inc.
Feb 2016 - Present
New York, US
qbeats revolutionizes the digital information ecosystem by introducing content valuation technology designed to help content creators isolate and maximize value per article. Optional go-to-market functionality can be overlaid to assist publishers, partners and sponsors in executing new information experiences.
Feb 2015 - Present
London, UK
The Royal Society for the encouragement of Arts, Manufactures and Commerce (RSA) is a global network of people committed to enriching society through ideas and action.
View allHide


Nov 2019 - Present
New York, NY, USA
Tom Speechley, Founder & CEO of SX2 Ventures, discusses the key aspects of dementia that all individuals should know. SX2 Ventures is a leader in innovation in human care, focused on the design of “next generation dementia care facilities”, using the latest evidence-based practices and technologies to improve the quality of care that residents receive.

Tom Speechley’s Education

First Class Honors Degree in Law